Gulf study reveals Real-World use of palbociclib for advanced breast cancer
NCT ID NCT04916509
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This completed study looked at medical records of 258 adults in Saudi Arabia, UAE, and other Gulf countries who received palbociclib (a targeted cancer pill) combined with hormone therapy for advanced HR+/HER2- breast cancer. Researchers aimed to describe patient characteristics, treatment patterns, and outcomes like how long the cancer was controlled. Since this is a retrospective study, it does not test a new treatment but provides real-world insights into how palbociclib is used in this region.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Palbociclib (a targeted cancer drug) combined with either an aromatase inhibitor or fulvestrant
What this could lead to
If successful, this study could help doctors in the Gulf region better understand how palbociclib is used in real-world practice and what outcomes patients experience.
What could go wrong
This is a retrospective study that only looks back at existing data, so it cannot prove cause and effect. Results may not apply to other regions or newer treatment approaches.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dubai Hospital
Dubai, United Arab Emirates
-
Hamad Medical Corporation
Doha, Qatar
-
King Abdulaziz Medical City National Guard Hospital
Jeddah, 22384, Saudi Arabia
-
King Abdulaziz Medical City National Guard Hospital Riyahd
Riyadh, 11426, Saudi Arabia
-
King Saud University Medical City Riyadh PO BOX 7805
Riyadh, 11472, Saudi Arabia
-
Mediclinic City Hospital
Dubai, United Arab Emirates
-
Tawam
Al Ain City, United Arab Emirates